Santiago E. Rossi MD, Presenter: Nothing to Disclose

Jane P. Ko MD, Abstract Co-Author: Nothing to Disclose

Ignacio Rossi, Abstract Co-Author: Nothing to Disclose

Chitra Viswanathan MD, Abstract Co-Author: Nothing to Disclose

Mylene Thi Mytien Truong MD, Abstract Co-Author: Nothing to Disclose

Jeremy J. Erasmus MD, Abstract Co-Author: Nothing to Disclose

- To review the differential diagnoses of solitary solid and subsolid pulmonary nodules - To review strategies in evaluating and managing solitary solid and subsolid pulmonary nodules. - To discuss the imaging findings useful in differentiating benign form malignant lesions.

- Clinical Assessment - Imaging Evaluation Morphology Growth Enhancement Characteristics Metabolism: FDG-PET - Decision Analysis Integrating clinical and imaging features Management algorithms (follow up, biopsy, surgery)  

Noninvasive image-based assessment and management of solitary pulmonary nodules are evolving given advances in multidetector CT imaging technology, knowledge adquired from lung cancer screening studies, and understanding of the behavior of lung adenocarcinoma. Strategies for evaluating and managing solid and subsolid pulmonary nodules take into consideration lesion size, morphology, and growth rate as well as patients risk factors for malignancy, including age, smoking history,and hsitory of neoplasia. Although subsolid nodules can exhibit indolent behavior, it is important to identify the subset of lesions associated with invasive adenocarcinoma and requiring a more aggressive imaging and managment approach.

Rossi, S, Ko, J, Rossi, I, Viswanathan, C, Truong, M, Erasmus, J, Update in the Evaluation of the Solitary Pulmonary Nodule: Solid and Subsolid Lesions.  Radiological Society of North America 2012 Scientific Assembly and Annual Meeting, November 25 - November 30, 2012 ,Chicago IL. http://archive.rsna.org/2012/12033667.html